{"id":"W2077372959","doi":"10.1016/j.pharmthera.2009.11.001","title":"Glycaemic control in type 2 diabetes: Targets and new therapies","year":2009,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institute for Health and Care Research","keywords":"Incretin; Medicine; Type 2 Diabetes Mellitus; Type 2 diabetes; Intensive care medicine; Diabetes mellitus; Disease; Bioinformatics; Pharmacology; Internal medicine; Endocrinology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008245301,0.001411301,0.003165866,0.002120211,0.0002717703,0.001231928,0.0010475,0.00127746,0.003487671],"category_scores_gemma":[0.0007475324,0.0003991345,0.0006785489,0.002899039,0.0005492182,0.001686026,0.0007987513,0.002765899,0.002253194],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006661554,"about_ca_system_score_gemma":0.001158378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001271979,"about_ca_topic_score_gemma":0.002786533,"domain_scores_codex":[0.9997221,0.00004358657,0.00004321188,0.0000410606,0.0001239074,0.00002600896],"domain_scores_gemma":[0.9995946,0.0001858339,0.00007497291,0.00001118754,0.0000983885,0.00003497801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001789457,0.0001156537,0.000122426,0.01299939,0.0001477396,0.000158982,0.00002780273,0.0003686252,0.0008781711,0.001664663,0.03304936,0.9502883],"study_design_scores_gemma":[0.0001388515,0.000212809,0.001307973,0.005071627,0.0004060337,0.001276687,0.00006797116,0.0002881113,0.0003876492,0.002822203,0.9879811,0.00003886492],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005849711,0.9989994,0.00009958583,0.0001878211,0.000178749,0.000003992195,0.00001237702,0.000006018069,0.0004534561],"genre_scores_gemma":[0.0003283083,0.9987881,0.0002056738,0.0001577131,0.0002051769,0.00000466042,0.00001687076,7.483786e-7,0.0002927613],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003487671,"threshold_uncertainty_score":0.01166743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06878506968200675,"score_gpt":0.3732650511662632,"score_spread":0.3044799814842565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}